Compounds > thrombin receptor peptide sfllrnp
Page last updated: 2024-09-03

thrombin receptor peptide sfllrnp and orbofiban

thrombin receptor peptide sfllrnp has been researched along with orbofiban in 1 studies

Compound Research Comparison

Studies
(thrombin receptor peptide sfllrnp)		Trials
(thrombin receptor peptide sfllrnp)		Recent Studies (post-2010)
(thrombin receptor peptide sfllrnp)		Studies
(orbofiban)		Trials
(orbofiban)		Recent Studies (post-2010) (orbofiban)
92102948170

Protein Interaction Comparison

ProteinTaxonomythrombin receptor peptide sfllrnp (IC50)orbofiban (IC50)
Integrin beta-3Homo sapiens (human)0.1462
Integrin alpha-IIbHomo sapiens (human)0.1462

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feuerstein, GZ; Friedman, SM; Gibbs, SK; Racanelli, AL; Seiffert, DA; Zondlo, SC1

Other Studies

1 other study(ies) available for thrombin receptor peptide sfllrnp and orbofiban

ArticleYear
Differential effect of the GPIIb/IIIa antagonist orbofiban on human platelet aggregate formation in vitro.
    Thrombosis research, 2003, May-01, Volume: 110, Issue:2-3

    Topics: Adenosine Diphosphate; Alanine; Blood Platelets; Humans; In Vitro Techniques; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Time Factors

2003